These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11315722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
    Wilson EM, Joy Williams F, Lyn BE, Aird EG.
    Radiother Oncol; 2005 Mar; 74(3):307-14. PubMed ID: 15763312
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
    Thirion P, Holmberg O, Collins CD, O'Shea C, Moriarty M, Pomeroy M, O'Sullivan C, Buckney S, Armstrong J.
    Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
    [Abstract] [Full Text] [Related]

  • 5. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1087-96. PubMed ID: 16682145
    [Abstract] [Full Text] [Related]

  • 6. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1268-79. PubMed ID: 15001272
    [Abstract] [Full Text] [Related]

  • 7. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party.
    Macbeth FR, Wheldon TE, Girling DJ, Stephens RJ, Machin D, Bleehen NM, Lamont A, Radstone DJ, Reed NS.
    Clin Oncol (R Coll Radiol); 1996 Mar 15; 8(3):176-81. PubMed ID: 8814372
    [Abstract] [Full Text] [Related]

  • 8. Sudden myelopathy secondary to therapeutic total-body hyperthermia after spinal-cord irradiation.
    Douglas MA, Parks LC, Bebin J.
    N Engl J Med; 1981 Mar 05; 304(10):583-5. PubMed ID: 6256626
    [No Abstract] [Full Text] [Related]

  • 9. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment.
    Schwarz M, Van der Geer J, Van Herk M, Lebesque JV, Mijnheer BJ, Damen EM.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1260-9. PubMed ID: 16798418
    [Abstract] [Full Text] [Related]

  • 10. The influence of the dose per fraction on radiation damage to the myelum.
    den Hoed-Sijtsema S, Kaalen JG, Crezée P.
    Radiol Clin Biol; 1971 Jul 15; 40(2):89-99. PubMed ID: 5113759
    [No Abstract] [Full Text] [Related]

  • 11. Non oat cell lung carcinoma: is there a role for combined brachytherapy and external radiotherapy?
    Trodella L, Mantini G, Fusco V, Barina M.
    Rays; 1991 Jul 15; 16(1):64-70. PubMed ID: 1710811
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic effect of high-dose three-dimensional conformal radiotherapy and conventional radiotherapy for non-small-cell lung cancer.
    Xu SJ, Shi YS, Song HC, Chen LH.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct 15; 22(10):937-8. PubMed ID: 12377626
    [Abstract] [Full Text] [Related]

  • 13. Dose-response in stereotactic irradiation of lung tumors.
    Wulf J, Baier K, Mueller G, Flentje MP.
    Radiother Oncol; 2005 Oct 15; 77(1):83-7. PubMed ID: 16209896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB, Kramer GW, Noordijk EM, Leer JW.
    J Natl Cancer Inst; 2006 Dec 20; 98(24):1786-94. PubMed ID: 17179480
    [Abstract] [Full Text] [Related]

  • 17. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R, Fujino M, Yamazaki K, Onodera Y, Taguchi H, Katoh N, Hommura F, Oizumi S, Nishimura M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):374-81. PubMed ID: 18029106
    [Abstract] [Full Text] [Related]

  • 18. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
    Jeremic B.
    Radiother Oncol; 2004 May 01; 71(2):123-5. PubMed ID: 15110444
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.
    Kyas I, Hof H, Debus J, Schlegel W, Karger CP.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):768-74. PubMed ID: 17097829
    [Abstract] [Full Text] [Related]

  • 20. New approaches to radiotherapy as definitive treatment for inoperable lung cancer.
    Berman AT, Rengan R.
    Semin Thorac Cardiovasc Surg; 2008 Mar 01; 20(3):188-97. PubMed ID: 19038727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.